Biopharmaceutical company focused on developing treatments for rare diseases
- Year invested 2015
- Investment Stage Early
- Sectors
- Investment Status Current
- Website clementiapharma.com/contact-us/
- Company Status IPO/Public (NASDAQ: CMTA)
Biopharmaceutical company focused on developing treatments for rare diseases